id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-N-1876-0001,FDA,FDA-1999-N-1876,"Agency Information Collection Activities; Proposed Collection; Comment Request; Blood Establishment Registration and Product Listing, Form FDA 2830",Notice,60 Day Proposed Information Collection,2017-06-22T04:00:00Z,2017,6,1999-09-03T04:00:00Z,1999-11-03T04:59:59Z,2024-10-22T19:14:35Z,99–23002,0,0,09000064804e7686
FDA-1999-N-1876-0004,FDA,FDA-1999-N-1876,Agency Information Collection Activities; Announcement of OMB Approval; Blood Establishment Registration and Product Listing—Form FDA 2830,Notice,Notice of Approval,2017-06-22T04:00:00Z,2017,6,,,2024-10-22T19:26:08Z,00–5466,0,0,09000064804e7689
FDA-1999-N-1876-0003,FDA,FDA-1999-N-1876,Supporting Statement for OMB Information Collection,Supporting & Related Material,Statement (Supporting and Related Material),2017-06-22T04:00:00Z,2017,6,,,2024-10-22T19:30:05Z,,0,0,09000064804e7688
FDA-1999-N-1876-0002,FDA,FDA-1999-N-1876,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Blood Establishment Registration and Product Listing, Form FDA 2830",Notice,30 Day Proposed Information Collection,2017-06-22T04:00:00Z,2017,6,1999-12-20T05:00:00Z,2000-01-20T04:59:59Z,2024-10-22T19:18:29Z,99-32788,0,0,09000064804e7687